LLY vs COR
By Alex · Tickerpine
Eli Lilly and Company vs Cencora, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | COR |
|---|---|---|
| Price | $1,208.12 | $286.13 |
| Market cap | $1.08T | $55.67B |
| P/E ratio | 42.9 | 21.9 |
| ROE | 107.46% | 107.13% |
| Profit margin | 34.99% | 0.78% |
| Revenue growth | 55.50% | 3.80% |
| Dividend yield | 0.57% | 0.84% |
| Beta | 0.52 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs COR in plain English
- LLY is the bigger company — about 19.4× the market cap of COR.
- COR is cheaper on earnings (P/E 21.9 vs 42.9).
- LLY earns a higher return on equity (107% vs 107%).
- LLY is growing revenue faster (56% vs 4%).
- COR has the higher dividend yield (0.84% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
COR return calculator
See what $1,000 in Cencora, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.